berotek has been researched along with Bronchial Hyperreactivity in 12 studies
Fenoterol: A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.
fenoterol : A member of the class resorcinols that is 5-(1-hydroxyethyl)benzene-1,3-diol in which one of the methyl hydrogens is replaced by a 1-(4-hydroxyphenyl)propan-2-amino group. A beta2-adrenergic agonist, it is used (as the hydrobromide salt) as a bronchodilator in the management of reversible airway obstruction.
Bronchial Hyperreactivity: Tendency of the smooth muscle of the tracheobronchial tree to contract more intensely in response to a given stimulus than it does in the response seen in normal individuals. This condition is present in virtually all symptomatic patients with asthma. The most prominent manifestation of this smooth muscle contraction is a decrease in airway caliber that can be readily measured in the pulmonary function laboratory.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sixteen subjects with mild stable asthma participated in a randomized double blind study on the effects of low dose fenoterol against histamine induced bronchoconstriction." | 9.07 | Low dose fenoterol aerosol protects against histamine-induced bronchoconstriction in mild asthmatics: a dose response study. ( Magnussen, H; Rabe, KF, 1992) |
| "We examined the effects of two year's treatment of three inhaled beta 2-agonists (beta 2), such as salbutamol (S), procaterol (P) and fenoterol (F) on acetylcholine induced bronchial hyperresponsiveness (BHR) in mild approximately moderate asthmatics." | 6.18 | [Long-term effects of inhaled beta 2-agonists on bronchial hyperresponsiveness in asthmatics]. ( Ogawa, C; Sano, Y, 1996) |
| "Sixteen subjects with mild stable asthma participated in a randomized double blind study on the effects of low dose fenoterol against histamine induced bronchoconstriction." | 5.07 | Low dose fenoterol aerosol protects against histamine-induced bronchoconstriction in mild asthmatics: a dose response study. ( Magnussen, H; Rabe, KF, 1992) |
| "Chronic exposure of human isolated bronchi to beta2-adrenergic agonists, especially fenoterol, potentiates smooth muscle contraction in response to endothelin-1 (ET-1), a peptide implicated in chronic inflammatory airway diseases." | 3.73 | Phosphodiesterase 4 inhibitors modulate beta2-adrenoceptor agonist-induced human airway hyperresponsiveness. ( Advenier, C; Devillier, P; Fagon, JY; Faisy, C; Guerot, E; Naline, E; Risse, PA, 2006) |
| " At 72 h after the last inhalation of PRO, FEN or vehicle, the dose-response relationship between lung resistance (R(L)) and intravenously administered acetylcholine (ACh) was measured." | 1.31 | Airway responsiveness and airway remodeling after chronic exposure to procaterol and fenoterol in guinea pigs in vivo. ( Arakawa, H; Kato, M; Mochizuki, H; Morikawa, A; Nishimura, H; Ohki, Y; Sato, A; Tokuyama, K, 2002) |
| "Improved values were seen after treatment for hyperthyroidism although statistical significance was not reached." | 1.28 | Airway response to inhaled fenoterol in hyperthyroid patients before and after treatment. ( Behera, D; Dash, RJ; Jindal, SK; Roy, R, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faisy, C | 2 |
| Pinto, FM | 1 |
| Blouquit-Laye, S | 1 |
| Danel, C | 1 |
| Naline, E | 2 |
| Buenestado, A | 1 |
| Grassin Delyle, S | 1 |
| Burgel, PR | 1 |
| Chapelier, A | 1 |
| Advenier, C | 2 |
| Candenas, ML | 1 |
| Devillier, P | 2 |
| Nishimura, H | 1 |
| Tokuyama, K | 1 |
| Arakawa, H | 1 |
| Ohki, Y | 1 |
| Sato, A | 1 |
| Kato, M | 1 |
| Mochizuki, H | 1 |
| Morikawa, A | 1 |
| Witzenrath, M | 1 |
| Ahrens, B | 1 |
| Kube, SM | 1 |
| Braun, A | 1 |
| Hoymann, HG | 1 |
| Hocke, AC | 1 |
| Rosseau, S | 1 |
| Suttorp, N | 1 |
| Hamelmann, E | 1 |
| Schütte, H | 1 |
| Risse, PA | 1 |
| Guerot, E | 1 |
| Fagon, JY | 1 |
| Titova, EA | 1 |
| Dukov, LG | 1 |
| Leonova, NV | 1 |
| Titova, LA | 1 |
| Timofeev, VV | 1 |
| Granitova, LV | 1 |
| Fedoseev, GB | 1 |
| Emel'ianov, AV | 1 |
| Sinitsina, TM | 1 |
| Goncharova, VA | 1 |
| Ogawa, C | 1 |
| Sano, Y | 1 |
| Stefaniuk, NF | 1 |
| Ichinose, M | 1 |
| Takahashi, T | 1 |
| Sugiura, H | 1 |
| Endoh, N | 1 |
| Miura, M | 1 |
| Mashito, Y | 1 |
| Shirato, K | 1 |
| Katsunuma, T | 1 |
| Fujita, K | 1 |
| Mak, JC | 1 |
| Barnes, PJ | 1 |
| Ueno, K | 1 |
| Iikura, Y | 1 |
| Behera, D | 1 |
| Roy, R | 1 |
| Dash, RJ | 1 |
| Jindal, SK | 1 |
| Magnussen, H | 1 |
| Rabe, KF | 1 |
1 review available for berotek and Bronchial Hyperreactivity
| Article | Year |
|---|---|
[Long-term effects of inhaled beta 2-agonists on bronchial hyperresponsiveness in asthmatics].
Topics: Administration, Oral; Adrenergic beta-Agonists; Albuterol; Asthma; Bronchial Hyperreactivity; Fenote | 1996 |
2 trials available for berotek and Bronchial Hyperreactivity
| Article | Year |
|---|---|
[Long-term effects of inhaled beta 2-agonists on bronchial hyperresponsiveness in asthmatics].
Topics: Administration, Oral; Adrenergic beta-Agonists; Albuterol; Asthma; Bronchial Hyperreactivity; Fenote | 1996 |
Low dose fenoterol aerosol protects against histamine-induced bronchoconstriction in mild asthmatics: a dose response study.
Topics: Adult; Aerosols; Asthma; Bronchial Hyperreactivity; Bronchoconstriction; Dosage Forms; Dose-Response | 1992 |
10 other studies available for berotek and Bronchial Hyperreactivity
| Article | Year |
|---|---|
beta2-Agonist modulates epithelial gene expression involved in the T- and B-cell chemotaxis and induces airway sensitization in human isolated bronchi.
Topics: Adrenergic beta-Agonists; Aged; B-Lymphocytes; Bronchi; Bronchial Hyperreactivity; Bronchoconstricti | 2010 |
Airway responsiveness and airway remodeling after chronic exposure to procaterol and fenoterol in guinea pigs in vivo.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Airway Resistance; Animals; Bronchial Hyperrea | 2002 |
Detection of allergen-induced airway hyperresponsiveness in isolated mouse lungs.
Topics: Allergens; Animals; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoconstriction; Bro | 2006 |
Phosphodiesterase 4 inhibitors modulate beta2-adrenoceptor agonist-induced human airway hyperresponsiveness.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; | 2006 |
[Changes in external respiration function in response to berotek and histamine in diabetic patients].
Topics: Adolescent; Adult; Aged; Bronchial Hyperreactivity; Bronchoconstriction; Bronchodilator Agents; Diab | 2008 |
[The therapeutic potentials of Ditec in bronchial asthma patients].
Topics: Adult; Aerosols; Albuterol; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Cromolyn | 1995 |
[Bronchial reactivity in patients with primary and recurrent pneumonias].
Topics: Adolescent; Adult; Bronchial Hyperreactivity; Bronchodilator Agents; Chronic Disease; Cold Temperatu | 1998 |
Baseline airway hyperresponsiveness and its reversible component: role of airway inflammation and airway calibre.
Topics: Administration, Inhalation; Adult; Anti-Asthmatic Agents; Asthma; Beclomethasone; Bronchial Hyperrea | 2000 |
Beta-adrenergic agonists and bronchial hyperreactivity: role of beta2-adrenergic and tachykinin neurokinin-2 receptors.
Topics: Adrenergic beta-Agonists; Animals; Asthma; Bronchial Hyperreactivity; Cattle; Fenoterol; Guinea Pigs | 2000 |
Airway response to inhaled fenoterol in hyperthyroid patients before and after treatment.
Topics: Administration, Inhalation; Adult; Bronchial Hyperreactivity; Female; Fenoterol; Forced Expiratory V | 1992 |